跳至主要内容
临床试验/NCT07473856
NCT07473856尚未招募不适用

Long-term Use of Intrapulmonary Percussive Ventilation for Preventing Hospitalizations Due to Respiratory Decompensation in Children With Multiple Disabilities: A Multicenter Randomized Controlled Trial.

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 146 人开始时间: 2026年3月1日最近更新:
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
146
试验地点
1
主要终点
Number of readmissions with respiratory decompensation

研究概览

简要总结

Chronic respiratory failure is the leading cause of morbidity and mortality in children with multiple disabilities. Musculoskeletal disorders, swallowing disorders and ventilatory control abnormalities lead to progressive respiratory impairment, causing episodes of respiratory decompensation (RD). These are the leading cause of mortality (50 to 80%, average age of death: 21 years) and the cause of repeated hospitalizations.

Respiratory care for these children is therefore a major challenge. In respiratory physiotherapy, this can be achieved through manual techniques and/or instrumental techniques such as intrapulmonary percussive ventilation (IPV), which is particularly useful in this population because it does not require active cooperation.

The main objective of this study is to evaluate, in children with multiple disabilities, the effectiveness at 18 months of using an IPV at home and by carers, combined with standard respiratory physiotherapy, compared with manual respiratory physiotherapy alone.This is a multicenter, randomized controlled superiority trial with two parallel groups.

All centers will recruit children aged 1 to 16 with multiple disabilities, during hospitalization with respiratory decompensation (RD). After consent has been signed by the parents or legal guardians, the patient will be randomized into one of the two study groups:

  • Control group: manual respiratory physiotherapy.
  • Intervention group: intrapulmonary Percussive Ventilation (IPV)

详细描述

IPV is used in France in different ways, depending on the center and service practices, as a complement to manual techniques.

At Armand Trousseau University Hospital, our experience over the past five years with more than 50 children suggests that the use of IPV by carers in their home environment. This is done as a complement to private manual physiotherapy sessions after training by a professional.

However, the benefits and impact of IPV on patients' respiratory development remain largely unstudied, particularly in patients with multiple disabilities. This multicenter randomized controlled study could provide recommendations for the respiratory management of these patients.

The main objective of this study is to evaluate, in children with multiple disabilities, the effectiveness at 18 months of using an IPV in the home and by carers, combined with standard respiratory physiotherapy, compared with manual respiratory physiotherapy alone. The primary endpoint is the number of rehospitalizations for RD at 18 months following the index hospitalization.

All centers will recruit children aged 1 to 16 with multiple disabilities, during hospitalization with Respiratory Decompensation (RD). the patient will be randomized into one of the two study groups:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Year 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Polyhandicap defined by:
  • Causal brain injury or lesion occurring before the age of 3 years,
  • Severe or profound intellectual disability according to DSM IV definition
  • Motor disability: paraplegia/quadriplegia, hemiparesis, ataxia, and/or extrapyramidal motor disorders,
  • Gross Motor Function Classification System (GMFCS) score of IV or V,
  • Functional Independence Measure (FIM) score < 55,
  • Age: 1 to 16 years,
  • Hospitalization of the patient with respiratory decompensation (RD),
  • Informed consent from parents/legal guardians

排除标准

  • Associated neuromuscular disease
  • Daily use of intrapulmonary percussive ventilation for more than 3 consecutive months within the 6 months prior to inclusion,
  • Daily use of a cough assistance device such as an insufflator-exsufflator for more than 3 consecutive months within the 6 months prior to inclusion,
  • Contraindications for the use of the medical device:
  • Pneumothorax,
  • Hypotension or hemodynamic instability,
  • Hemoptysis,
  • Participation in another interventional study.
  • Patients with tracheobronchial collapse during expiration

研究组 & 干预措施

IPV + Manual Respiratory Physiotherapy

Experimental

After the device has been adjusted to suit the child and carers have been trained during hospitalisation, IPV will be prescribed for use by carers at home for 15 minutes, five times a week, in addition to manual RP prescribed 2 to 3 times a week in private practice or at home.

干预措施: Intrapulmonary Percussive Ventilation IPV (Procedure)

Manual Respiratory Physiotherapy Only

No Intervention

no intervention, current practice

结局指标

主要结局

Number of readmissions with respiratory decompensation

时间窗: 18 months after the index hospitalization with respiratory decompensation

次要结局

  • Number of days of hospitalization(18 months after the index hospitalization with respiratory decompensation.)
  • Number and duration of respiratory exacerbations managed at home, emergency visits not followed by hospitalizations and unscheduled consultations(18 months after the index hospitalization with respiratory decompensation.)
  • Number of days on antibiotics for respiratory issues(18 months after the index hospitalization with respiratory decompensation.)
  • PolyQol scale(At month 1, month 3, month 6, month 12, and month 18)
  • PERKINE Questionnaire(At month 1, month 3, month 6, month 12, and month 18)
  • Cost-Effectiveness Analysis(At the end of the study)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验